Absence of p53: No Effect in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

Familial amyotrophic lateral sclerosis (ALS) has been linked in some families to dominantly inherited mutations in the gene encoding copper-zinc superoxide dismutase 1 (Cu-Zn SOD1). Transgenic mice expressing a mutant human Cu-Zn SOD1 (G93A) develop a dominantly inherited adult-onset paralytic disorder that replicates many of the clinical and pathological features of familial ALS. Increased p53 immunoreactivity has been reported in the motor cortex and spinal ventral horns of postmortem tissue from ALS patients. The nuclear phosphoprotein p53 is an important regulator of cellular proliferation, and increasing evidence supports the role of p53 in regulating cellular apoptosis. To assess the role of p53-mediated apoptosis in amyotrophic lateral sclerosis, mice deficient in both p53 alleles (p53-/-) were crossed with transgenic mice expressing the G93A mutant (G93A+), creating novel transgenic knockout mice. The animals (p53 +/+G93A+, p53+/-G93A+, p53-/-G93A+) were examined at regular intervals for cage activity, upper and lower extremity strength, and mortality. At 120 days from birth mice from each genotype were sacrificed, and L2-L3 anterior horn motor neurons were counted. There was no significant difference in time to onset of behavioral decline, mortality, or motor neuron degeneration between the different genotypes. Despite evidence that p53 plays an important role after acute neuronal injury, the current study suggests that p53 is not significantly involved in cell death in the G93A+ transgenic mouse model of familial ALS.

[1]  D. Schiffer,et al.  Lack of apoptosis in mice with ALS , 1999, Nature Medicine.

[2]  J. Gitlin,et al.  The Role of Copper in Neurodegenerative Disease , 1999, Neurobiology of Disease.

[3]  J. B. Martin,et al.  Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.

[4]  Mark D. Johnson,et al.  Contribution of p53-Dependent Caspase Activation to Neuronal Cell Death Declines with Neuronal Maturation , 1999, The Journal of Neuroscience.

[5]  Mark D. Johnson,et al.  Evidence for involvement of Bax and p53, but not caspases, in radiation‐induced cell death of cultured postnatal hippocampal neurons , 1998, Journal of neuroscience research.

[6]  M. Beal,et al.  Elevated “Hydroxyl Radical” Generation In Vivo in an Animal Model of Amyotrophic Lateral Sclerosis , 1998, Journal of neurochemistry.

[7]  J. Wands,et al.  P53- and CD95-associated apoptosis in neurodegenerative diseases. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[8]  Mark D. Johnson,et al.  Mechanisms of neuronal cell death , 1998 .

[9]  Robert H. Brown,et al.  Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.

[10]  D. Duval,et al.  Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis , 1997, Journal of the Neurological Sciences.

[11]  Robert H. Brown,et al.  Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.

[12]  Robert H. Brown,et al.  Amyotrophic lateral sclerosis. Insights from genetics. , 1997, Archives of neurology.

[13]  J. Cadet,et al.  Methamphetamine-induced serotonin neurotoxicity is attenuated in p53-knockout mice , 1997, Brain Research.

[14]  M. Gurney,et al.  Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.

[15]  J. Cadet,et al.  p53‐Knockout Mice Are Protected Against the Long‐Term Effects of Methamphetamine on Dopaminergic Terminals and Cell Bodies , 1997, Journal of neurochemistry.

[16]  M. Dubois‐Dauphin,et al.  Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. , 1997, Science.

[17]  Junying Yuan,et al.  Inhibition of ICE slows ALS in mice , 1997, Nature.

[18]  H. Ozawa,et al.  The In Vivo Time Course for Elimination of Adrenalectomy-Induced Apoptotic Profiles from the Granule Cell Layer of the Rat Hippocampus , 1997, The Journal of Neuroscience.

[19]  E. Stadtman,et al.  A Familial Amyotrophic Lateral Sclerosis-associated A4V Cu,Zn-Superoxide Dismutase Mutant Has a Lower Km for Hydrogen Peroxide , 1997, The Journal of Biological Chemistry.

[20]  M. Gurney,et al.  Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis , 1997, Annals of neurology.

[21]  C. Portera-Cailliau,et al.  Excitotoxic neuronal death in the immature brain is an apoptosis‐necrosis morphological continuum , 1997, The Journal of comparative neurology.

[22]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[23]  S. Schreiber,et al.  p53‐deficient mice are protected against adrenalectomy‐induced apoptosis , 1996, Neuroreport.

[24]  P. Schwartzkroin,et al.  Evidence for p53-Mediated Modulation of Neuronal Viability , 1996, The Journal of Neuroscience.

[25]  J. Bennett,et al.  Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[26]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[27]  I. Kanazawa,et al.  In situ nick end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid , 1996, Neuroscience Letters.

[28]  L. Donehower,et al.  Loss of the p53 tumor suppressor gene protects neurons from kainate- induced cell death , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  S. Aizawa,et al.  p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons , 1996, Neuroscience Letters.

[30]  Robert H. Brown,et al.  Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function , 1995, Current Opinion in Neurobiology.

[31]  Kaitlin M Wood,et al.  The role of free radicals and p53 in neuron apoptosis in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  A. Levine,et al.  p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches , 1995, Cell.

[33]  C. Prives,et al.  Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.

[34]  B. Kraupp,et al.  In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.

[35]  Robert H. Brown,et al.  Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.

[36]  J. Morrison,et al.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Rowland,et al.  Merritt's textbook of neurology , 1995 .

[38]  R. Crumrine,et al.  Attenuation of p53 Expression Protects against Focal Ischemic Damage in Transgenic Mice , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  T. Timme,et al.  Rapid allelotype analysis of p53 knockout mice. , 1994, BioTechniques.

[40]  D. Fisher.  Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[41]  M. Baudry,et al.  p53 induction is associated with neuronal damage in the central nervous system. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Hartung,et al.  Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[43]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[44]  R. Bristow,et al.  Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. , 1994, Oncogene.

[45]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[46]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[47]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[48]  P. Shaw,et al.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[50]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[51]  A. Delacourte,et al.  Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome , 1991, Brain Research.

[52]  J. Haines,et al.  Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. , 1991, The New England journal of medicine.

[53]  M. Lovett,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Adams,et al.  Principles of Neurology , 1996 .